UK health tech company Lilli raises £4.5 million for scale up
Funds to fuel rollout of machine learning-enabled care solution
London, UK, 18th March, 2021: Lilli, the UK SaaS company using machine learning to revolutionise home care, has raised £4.5 million in a pre-Series A funding round organised by West Hill Capital that was 50% over-subscribed.
The funding comes eight months into CEO Gren Paull’s tenure and follows a series of strategic senior appointments, including former management consultant Kelly Hudson as CSO, and CCO Nick Weston, formerly of O2.
Having recently pivoted from hardware to software and undertaken a major rebrand, Lilli’s purpose-led approach and smart technology fulfils a growing need in the UK for independent living, alleviating the pressures of caring for an ageing UK population with long-term health conditions, and advocates accessibility to the technology for all those that need it.
The solution uses machine learning to analyse a range of data sources, such as temperature, motion, and power usage. This provides real-time data and insights to those responsible for caregiving to provide reassurance about wellbeing and highlight any causes for concern. As a result, over-stretched health and social care providers can intervene earlier, whilst monitoring at a distance, reducing the need for hospital admissions and lowering costs.
Lilli’s technology has already undergone trials with Brent Council and is about to commence a 100-person trial with Dorset County Council, both through Lilli’s Independent Future Group. The group, formed by Lilli, is a coalition of forward-thinking local authorities and professional care associations which aims to explore the further use of technology and help address the changing needs of care. Discussions are also in progress with 17 local authorities and Clinical Commissioning Groups about additional implementations.
Gren Paull, CEO, Lilli, said:
“The timing for this new preventative approach to care and integration of our smart technology is crucial in meeting the needs of ageing population, this has only been exacerbated by COVID 19. The role of technology has a vital role to play in the future success of care delivery across the UK and globally.”
Robert Forbes Caie, managing partner West Hill Capital, added:
“West Hill is delighted to be supporting Lilli enabling them to bring its pioneering preventative technology to the NHS and social care sector. Lilli’s proprietary technology is empowering people to live independently within their own homes for longer, when in the past, an individual’s age, ability or condition would have required constant supervision or care. West Hill seeks to identify companies harbouring strong IP that are potentially globally scalable and we feel that Lilli certainly exhibits these qualities.”
Lilli supports independent living by giving people choice in how and where they spend their lives regardless of their age, condition or financial situation.
In the UK, the number of people living with self-limiting conditions is increasing. The resulting strain on social care resources means that providing ongoing monitoring for people is a challenge. As this problem escalates, caring for an ageing population will become more demanding over the next decade.
Lilli’s smart non-intrusive technology enables detailed, around-the-clock monitoring of behaviours. By using machine learning in observing patterns and trends amongst users we can identify changes in behaviours before conditions become acute, supporting users expediently and reducing hospital visits. The technology has the potential to deliver a cost effective and non-intrusive monitoring system for health and social care practitioners, family or carers which will support individuals with self-limiting health conditions to maintain their independence at home for as long as possible.
Lilli offers immense ease-of-use and implementation at scale, using the UK phone network or Wi-fi to provide carers or care organisations with updates and notifications for each individual monitored. Lilli is set to be capable of integration with wearable devices such as smart watches from leading consumer technology brands. It also meets the standards required for data transfer with NHS patient record systems in the UK.
Please visit: https://www.intelligentlilli.com
For more information, please contact:
+44 (0)1252 727313 ext.